Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis

Post kala-azar dermal leishmaniasis (PKDL), a clinical sequela of visceral leishmaniasis (VL), plays a critical role in the anthroponotic transmission of VL, particularly in the Indian subcontinent (ISC). The early, accurate, and feasible diagnosis of PKDL is essential for the attainment and sustena...

Full description

Bibliographic Details
Main Authors: Keerti Kaumudee Dixit, Ruchi Singh, Poonam Salotra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2020;volume=65;issue=6;spage=465;epage=472;aulast=Dixit
id doaj-cc1fabe4201040728fc80d81d6329e66
record_format Article
spelling doaj-cc1fabe4201040728fc80d81d6329e662020-11-25T03:57:39ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112020-01-0165646547210.4103/ijd.IJD_311_19Advancement in molecular diagnosis of post kala-azar dermal leishmaniasisKeerti Kaumudee DixitRuchi SinghPoonam SalotraPost kala-azar dermal leishmaniasis (PKDL), a clinical sequela of visceral leishmaniasis (VL), plays a critical role in the anthroponotic transmission of VL, particularly in the Indian subcontinent (ISC). The early, accurate, and feasible diagnosis of PKDL is essential for the attainment and sustenance of VL elimination goal in ISC. PKDL poses a stumbling block for this goal, considering the heterogeneity presented with regard to time after cure of VL and onset of PKDL, chronicity, and clinical variations. In most of the endemic regions the diagnosis is based on clinical examination, previous history of VL, by ruling out other disorders, and by the response to treatment. The conventional microscopic examination involving the demonstration of Leishman–Donovan bodies (LDB) in macrophages is pathognomonic, however, the method faces constraints in terms of being invasive, less sensitive, technically demanding, and difficult to be applied in field conditions. Serological evidences are of limited use because antileishmanial antibodies remain positive for years after VL treatment. Molecular tools such as PCR, nested-PCR, Q-PCR overcome these constraints and have become increasingly popular due to their high sensitivity and specificity along with their applicability in diverse clinical samples. Molecular methods not only play a key role in early detection but also provide quantification and monitoring of treatment effectiveness. NCBI PubMed search tool was used for locating, selecting, and extracting research articles pertinent for this review article by using various related terminologies on the molecular diagnosis of leishmaniasis.http://www.e-ijd.org/article.asp?issn=0019-5154;year=2020;volume=65;issue=6;spage=465;epage=472;aulast=Dixitlamppost kala-azar dermal leishmaniasisrk39 rdtvl elimination
collection DOAJ
language English
format Article
sources DOAJ
author Keerti Kaumudee Dixit
Ruchi Singh
Poonam Salotra
spellingShingle Keerti Kaumudee Dixit
Ruchi Singh
Poonam Salotra
Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
Indian Journal of Dermatology
lamp
post kala-azar dermal leishmaniasis
rk39 rdt
vl elimination
author_facet Keerti Kaumudee Dixit
Ruchi Singh
Poonam Salotra
author_sort Keerti Kaumudee Dixit
title Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
title_short Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
title_full Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
title_fullStr Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
title_full_unstemmed Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
title_sort advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Dermatology
issn 0019-5154
1998-3611
publishDate 2020-01-01
description Post kala-azar dermal leishmaniasis (PKDL), a clinical sequela of visceral leishmaniasis (VL), plays a critical role in the anthroponotic transmission of VL, particularly in the Indian subcontinent (ISC). The early, accurate, and feasible diagnosis of PKDL is essential for the attainment and sustenance of VL elimination goal in ISC. PKDL poses a stumbling block for this goal, considering the heterogeneity presented with regard to time after cure of VL and onset of PKDL, chronicity, and clinical variations. In most of the endemic regions the diagnosis is based on clinical examination, previous history of VL, by ruling out other disorders, and by the response to treatment. The conventional microscopic examination involving the demonstration of Leishman–Donovan bodies (LDB) in macrophages is pathognomonic, however, the method faces constraints in terms of being invasive, less sensitive, technically demanding, and difficult to be applied in field conditions. Serological evidences are of limited use because antileishmanial antibodies remain positive for years after VL treatment. Molecular tools such as PCR, nested-PCR, Q-PCR overcome these constraints and have become increasingly popular due to their high sensitivity and specificity along with their applicability in diverse clinical samples. Molecular methods not only play a key role in early detection but also provide quantification and monitoring of treatment effectiveness. NCBI PubMed search tool was used for locating, selecting, and extracting research articles pertinent for this review article by using various related terminologies on the molecular diagnosis of leishmaniasis.
topic lamp
post kala-azar dermal leishmaniasis
rk39 rdt
vl elimination
url http://www.e-ijd.org/article.asp?issn=0019-5154;year=2020;volume=65;issue=6;spage=465;epage=472;aulast=Dixit
work_keys_str_mv AT keertikaumudeedixit advancementinmoleculardiagnosisofpostkalaazardermalleishmaniasis
AT ruchisingh advancementinmoleculardiagnosisofpostkalaazardermalleishmaniasis
AT poonamsalotra advancementinmoleculardiagnosisofpostkalaazardermalleishmaniasis
_version_ 1724459507382222848